Literature DB >> 13617475

Therapeutic implications of differential effects of new phenothiazine compounds.

F A FREYHAN.   

Abstract

Entities:  

Keywords:  PHENOTHIAZINE/related compounds

Mesh：

Substances：

Year:  1959        PMID： 13617475     DOI： 10.1176/ajp.115.7.577

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  9 in total

1.  COMPARISON OF BUTAPERAZINE AND PERPHENAZINE: A DOUBLE-BLIND CONTROLLED STUDY.

Authors:  P SHARPLEY; G HEISTAD; B C SCHIELE
Journal:  Psychopharmacologia       Date:  1964-02-12

2.  Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.

Authors:  Lior Greenbaum; Robert C Smith; Mordechai Lorberboym; Anna Alkelai; Polina Zozulinsky; Tzuri Lifschytz; Tzuri Lifshytz; Yoav Kohn; Ruth Djaldetti; Bernard Lerer
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

3.  NEW DRUGS.

Authors: 
Journal:  Can Med Assoc J       Date:  1959-05-01       Impact factor: 8.262

4.  Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.

Authors:  T E Hanlon; C Schoenrich; W Freinek; I Turek; A A Kurland
Journal:  Psychopharmacologia       Date:  1966

5.  The clinical phenomenon of akathisia.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

Review 6.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

7.  Phenothiazine ataraxics. Extrapyramidal reactions.

Authors:  H D CAIN; M MALCOLM
Journal:  Calif Med       Date:  1960-07

8.  Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.

Authors:  Ana Alkelai; Lior Greenbaum; Amihai Rigbi; Kyra Kanyas; Bernard Lerer
Journal:  Psychopharmacology (Berl)       Date:  2009-08-13       Impact factor: 4.530

Review 9.  Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes.

Authors:  Lior Greenbaum; Bernard Lerer
Journal:  Front Neurol       Date:  2015-02-20       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.